EarningsQ2 2023 Earnings Report

Arovella Therapeutics Limited (E4NA) Q2 2023 Earnings Report

0 Followers

DE:E4NA Q2 2023 EPS Results

Actual EPS>-€0.01

Consensus EPS―

Beat/Miss―

One Year Ago EPS>-€0.01

Actual Revenue€231.62K

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+1580.26%

QuarterQ2 2023

Date02/22/2023

TimeAfter Close

Conference CallWednesday, February 22, 2023

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Sep 02, 2026	2026 (Q4)	- / >-0.01	-0.004	33.33% (<+0.01)
Feb 19, 2026	2026 (Q2)	- / >-0.01	>-0.001	-100.00% (>-0.01)
Aug 27, 2025	2025 (Q4)	>-0.01 / >-0.01	-0.003	-20.00% (>-0.01)
Feb 26, 2025	2025 (Q2)	>-0.01 / >-0.01	-0.002	75.00% (<+0.01)
Aug 21, 2024	2024 (Q4)	- / >-0.01	-0.005	37.50% (<+0.01)
Feb 28, 2024	2024 (Q2)	- / >-0.01	-0.004	33.33% (<+0.01)
Aug 31, 2023	2023 (Q4)	- / >-0.01	-0.005	0.00% (0.00)
Feb 22, 2023	2023 (Q2)	- / >-0.01	-0.005	25.00% (<+0.01)
Aug 31, 2022	2022 (Q4)	- / >-0.01	-0.004	-14.29% (>-0.01)
Feb 27, 2022	2022 (Q2)	- / >-0.01	-0.384	98.73% (+0.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed